Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Cook Political Report's Jessica Taylor Talks US Midterms
07:21

PIMCO's Libby Cantrill Talks Money, Markets, and Midterms
08:11

British Chancellor John Healey Talks 'Jewel' In UK's Economic Crown
04:01